Raymond DuBois honored for landmark work in colon cancer

March 13, 2002

NASHVILLE, Tenn. - Raymond N. DuBois Jr., M.D., Ph.D., is the 26th recipient of the Richard and Hinda Rosenthal Foundation Award to recognize research that has made or promises to make a notable contribution to improved cancer care. The award is presented annually by the American Association for Cancer Research (AACR). It will be awarded during the AACR's annual meeting in April.

The AACR is honoring DuBois for his seminal work in colorectal cancer research, including his contributions to understanding the role of the enzyme cyclooxygenase-2 (COX-2). His work has been the catalyst for the expanding field or research into COX-2 and the carcinogenic process, the AACR said in a statement. It has already had significant impact on patient care, with the recent approval of celecoxib, a COX-2 inhibitor, for the reduction of polyp formation in patients with familial adenomatous polyposis, an inherited disease in which hundreds of polyps form and, if left untreated, develop into tumors.

Clinical trials are under way to determine the usefulness of this drug in individuals who face a more typical risk of colorectal cancer. Additional work by DuBois and others suggests that COX-2 inhibitors may also play a role in treating lung and other forms of cancer; clinical trials are also beginning in this area.
-end-
DuBois is the associate director for Cancer Prevention, Control and Population-Based Research at the Vanderbilt-Ingram Cancer Center in Nashville, Tenn. He also is Mina Cobb Wallace Professor of Cancer Prevention and chief of the division of Gastroenterology, Hepatology and Nutrition.

The Vanderbilt-Ingram Cancer Center is the only Comprehensive Cancer Center designated by the National Cancer Institute in Tennessee, and one of only 41 nationwide. This designation, the highest ranking awarded to cancer centers by the world's foremost authority on cancer, recognizes research excellence in cancer causes, development, treatment and prevention, as well as a demonstrated commitment to community education, information and outreach. To learn more, please visit www.vicc.org.

Vanderbilt University Medical Center

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.